Syndax Pharmaceuticals Inc (SNDX)
18.89
+0.73
(+4.02%)
USD |
NASDAQ |
Sep 27, 16:00
18.88
-0.01
(-0.05%)
After-Hours: 20:00
Syndax Pharmaceuticals Total Long Term Debt (Quarterly): 0.00 for June 30, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 20.21M |
| March 31, 2022 | 20.05M |
| December 31, 2021 | 19.90M |
| September 30, 2021 | 20.48M |
| June 30, 2021 | 20.35M |
| March 31, 2021 | 20.23M |
| December 31, 2020 | 20.12M |
| September 30, 2020 | 20.01M |
| June 30, 2020 | 19.90M |
| March 31, 2020 | 19.79M |
| December 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 8.175M |
| June 30, 2015 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2019
20.48M
Maximum
Sep 2021
10.05M
Average
9.896M
Median
Total Long Term Debt (Quarterly) Benchmarks
| Incyte Corp | 0.00 |
| Trevena Inc | 31.53M |
| Bristol-Myers Squibb Co | 52.39B |
| Arcus Biosciences Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 0.696M |